Henry H. Ji Ph.d.

Biography

Dr. Henry H. Ji, Ph.D., co-founded Sorrento Therapeutics, Inc. (STI) in January 2006 and has been its Chief Executive Officer and President since September 2012 and also has been its Chairman since August 16, 2017. Dr. Ji served as Interim Chief Executive Officer of Sorrento Therapeutics from April 2011 to September 2012, Chief Scientific Officer since November 2008 until September 2012 and Secretary since September 21, 2009 until June 2011. He has more than 18 years of biotechnology and biopharmaceutical experience. In 2002, he founded BioVintage, Inc. and served as its President since 2002. From 2001 to 2002, Dr. Ji served as Vice President of CombiMatrix Corporation, a publicly traded biotechnology company that develops proprietary technologies, including products and services in the areas of drug development, genetic analysis, molecular diagnostics and nanotechnology. From 1999 to 2001, he served as Director of Business Development and in 2001 as Vice President of Stratagene Corporation (later acquired by AgilentTechnologies, Inc.) where he was responsible for novel technology and product licensing and development. In 1997, Dr. Ji co-founded Stratagene Genomics, Inc., a wholly owned subsidiary of Stratagene Corporation and served as its President and Chief Executive Officer from its founding until 1999. He has been a Director of Sorrento Therapeutics, Inc. since January 2006. He served as a Director of NantKwest, Inc. from December 2014 to December 31, 2015. He served as a Director at Quikbyte Software, Inc. since September 21, 2009. He is the holder of several issued and pending patents in the life science research field and is the sole inventor of STI’s intellectual property. Dr. Ji has a Ph.D. in Animal Physiology from the University of Minnesota and a B.S. in Biochemistry from the Fudan University.

Research Interest

Medicine